StonvexLoading…
StonvexStonvexStonvexCore line items from WSM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-01 | Annual 2025 2025-02-02 | Annual 2024 2024-01-28 | Annual 2023 2023-01-29 |
|---|---|---|---|---|
Revenue | $7.81B | $7.71B | $7.75B | $8.67B |
Operating Income | $1.42B | $1.43B | $1.24B | $1.50B |
Net Income | $1.09B | $1.13B | $949.76M | $1.13B |
EPS (Diluted) | $8.84 | $8.79 | $7.28 | $8.16 |
Total Assets | $5.41B | $5.30B | $5.27B | $4.66B |
Total Liabilities | $3.33B | $3.16B | $3.15B | $2.96B |
Cash & Equivalents | $1.02B | $1.21B | $1.26B | $367.34M |
Free Cash Flow OCF − CapEx | $1.06B | $1.14B | $1.49B | $698.71M |
Shares Outstanding | 118.77M | 123.13M | 128.30M | 66.23M |